Screener
Ginkgo Bioworks DNA Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Other non-current liabilities | (6,124) | 5,156 |
| Net cash used in operating activities - continuing operations | (88,606) | (81,305) |
| Net cash used in operating activities - discontinued operations | (2,353) | (10,470) |
| Net cash used in operating activities | (90,959) | (91,775) |
| Cash flows from investing activities: | ||
| Purchases of marketable debt securities | (127,445) | (320,132) |
| Maturities of marketable debt securities | 166,168 | 64,958 |
| Purchases of property and equipment | (4,552) | (7,660) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's operating cash flow?
- Ginkgo Bioworks (DNA) reported operating cash flow of -$44.27M in Q2 2026.
- How has Ginkgo Bioworks's operating cash flow changed year-over-year?
- Ginkgo Bioworks's operating cash flow decreased by 10.0% year-over-year, from -$40.25M to -$44.27M.
- What is the long-term trend for Ginkgo Bioworks's operating cash flow?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's operating cash flow has grown at a -9.4% compound annual growth rate (CAGR), from -$253.82M to -$171.06M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Ginkgo Bioworks's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude